Literature DB >> 28593397

5-ALA fluorescence behavior of cerebral infectious and inflammatory disease.

Julia Steinmann1, Marion Rapp1, Bernd Turowski2, Hans-Jakob Steiger1, Jan Frederick Cornelius1, Michael Sabel3, Marcel A Kamp4.   

Abstract

Entities:  

Year:  2017        PMID： 28593397     DOI： 10.1007/s10143-017-0867-3

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN： 0344-5607            Impact factor:   3.042


× No keyword cloud information.
  14 in total

1.  In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid.

Authors:  W Stummer; S Stocker; A Novotny; A Heimann; O Sauer; O Kempski; N Plesnila; J Wietzorrek; H J Reulen
Journal:  J Photochem Photobiol B       Date:  1998-09       Impact factor: 6.252

2.  5-aminolevulinic acid (5-ALA) fluorescence in infectious disease of the brain.

Authors:  Benjamin Voellger; Johann Klein; Christian Mawrin; Raimund Firsching
Journal:  Acta Neurochir (Wien)       Date:  2014-07-02       Impact factor: 2.216

3.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

4.  Analysis of the surgical benefits of 5-ALA-induced fluorescence in intracranial meningiomas: experience in 204 meningiomas.

Authors:  Matthias Millesi; Barbara Kiesel; Mario Mischkulnig; Mauricio Martínez-Moreno; Adelheid Wöhrer; Stefan Wolfsberger; Engelbert Knosp; Georg Widhalm
Journal:  J Neurosurg       Date:  2016-03-25       Impact factor: 5.115

5.  Impact of 5-aminolevulinic acid fluorescence-guided surgery on the extent of resection of meningiomas--with special regard to high-grade tumors.

Authors:  J F Cornelius; P J Slotty; M A Kamp; T M Schneiderhan; H J Steiger; M El-Khatib
Journal:  Photodiagnosis Photodyn Ther       Date:  2014-08-10       Impact factor: 3.631

6.  Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases.

Authors:  Serge Marbacher; Elisabeth Klinger; Lucia Schwyzer; Ingeborg Fischer; Edin Nevzati; Michael Diepers; Ulrich Roelcke; Ali-Reza Fathi; Daniel Coluccia; Javier Fandino
Journal:  Neurosurg Focus       Date:  2014-02       Impact factor: 4.047

7.  5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study.

Authors:  Marcel A Kamp; Philipp Grosser; Jörg Felsberg; Philipp J Slotty; Hans-Jakob Steiger; Guido Reifenberger; Michael Sabel
Journal:  Acta Neurochir (Wien)       Date:  2011-11-12       Impact factor: 2.216

8.  5-Aminolevulinic Acid and (18)F-FET-PET as Metabolic Imaging Tools for Surgery of a Recurrent Skull Base Meningioma.

Authors:  Jan Frederick Cornelius; Philipp Jörg Slotty; Gabriele Stoffels; Norbert Galldiks; Karl Josef Langen; Hans Jakob Steiger
Journal:  J Neurol Surg B Skull Base       Date:  2013-04-01

9.  Is it a glioblastoma? In dubio pro 5-ALA!

Authors:  Marcel A Kamp; Antonio Santacroce; Samis Zella; Dorothea C Reichelt; Jörg Felsberg; Hans-Jakob Steiger; Jan Frederick Cornelius; Michael Sabel
Journal:  Acta Neurochir (Wien)       Date:  2012-05-11       Impact factor: 2.216

10.  5-ALA fluorescence of cerebral metastases and its impact for the local-in-brain progression.

Authors:  Marcel A Kamp; Igor Fischer; Julia Bühner; Bernd Turowski; Jan Frederick Cornelius; Hans-Jakob Steiger; Marion Rapp; Philipp J Slotty; Michael Sabel
Journal:  Oncotarget       Date:  2016-10-11
View more
  1 in total

1.  5-aminolevulinic acid fluorescence in tumefactive demyelinating lesion.

Authors:  Naohisa Miyagi; Shinji Nakashima; Tetsuya Negoto; Shinichirou Mori; Satoru Komaki; Motohiro Morioka; Yasuo Sugita
Journal:  Neurosurg Rev       Date:  2018-03-01       Impact factor: 3.042
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.